반응식
[CH3:1][C:2]1([CH3:17])[CH2:11][CH2:10][C:9]([CH3:13])([CH3:12])[C:8]2[CH:7]=[C:6]([C:14]([OH:16])=[O:15])[CH:5]=[CH:4][C:3]1=2.O[C:19]1[CH:29]=[CH:28][C:22]([C:23]([O:25][CH2:26][CH3:27])=[O:24])=[CH:21][CH:20]=1.C1(N=C=NC2CCCCC2)CCCCC1>CN(C)C1C=CN=CC=1.C(Cl)Cl>[CH3:1][C:2]1([CH3:17])[CH2:11][CH2:10][C:9]([CH3:12])([CH3:13])[C:8]2[CH:7]=[C:6]([C:14]([O:16][C:19]3[CH:29]=[CH:28][C:22]([C:23]([O:25][CH2:26][CH3:27])=[O:24])=[CH:21][CH:20]=3)=[O:15])[CH:5]=[CH:4][C:3]1=2참가 물질
반응물 3
생성물 1
시약·촉매·용매 2
실험 절차
A solution of 116 mg (0.5 mmol) of 5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-2-naphthoic acid, 58 mg (0.5 mmol) of ethyl 4-hydroxybenzoate, 117 mg (0.56 mmol) of 1,3-dicyclohexylcarbodiimide and 30 mg (0.25 mmol) of 4-dimethylaminopyridine in 15 ml of methylene chloride was stirred at room temperature for 12 hours. The reaction mixture was then filtered and the filtrate concentrated in-vacuo. The resultant residue was purified by flash chromatography (silica; 5% ethyl acetate in hexanes) to give the title compound as white crystals. PMR (CDCl3): δ 1.32 (6H, s), 1.36 (6H, s), 1.42 (3H, t, J~7.0 Hz), 1.73 (4H, s), 4.40 (2H, q, J~7.0 Hz), 7.28 (2H, d, J~8.1 Hz), 7.45 (1H, d, J~8.8 Hz), 7.93 (1H, dd, J~8.8 Hz, 1.8 Hz), 8.13 (2H, d, J~8.1 Hz), 8.14 (1H, s).
후처리
- filtrationThe reaction mixture was then filtered
- concentrationthe filtrate concentrated in-vacuo
- customThe resultant residue was purified by flash chromatography (silica; 5% ethyl acetate in hexanes)
출처 및 근거
- ORD 기록
- ord-0af8ec32ede14ba190806974841680ca
- 출처 데이터셋
- uspto-grants-1993_07
- 특허 번호
- US05231113
연결된 노트
불러오는 중…